Prudential Financial’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Prudential Financial's KPTI Position: Q3 2026 in Review
Prudential Financial opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 172,610 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings. This is a return to the name: Prudential Financial previously reported a position in KPTI as recently as Q4 2024.
Prudential Financial first reported a position in KPTI in Q4 2017 and has held it in 15 quarters since. The position peaked at $923K in Q1 2018. 92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Prudential Financial held 172,610 shares of Karyopharm Therapeutics worth $211K as of Q3 2026.
- Karyopharm Therapeutics was a new Prudential Financial position in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2297 holding.
- Prudential Financial first reported a position in Karyopharm Therapeutics in Q4 2017 and has held it in 15 quarters since.
- Prudential Financial's Karyopharm Therapeutics position peaked at $923K in Q1 2018.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.